Company Name
Chia Tai Tianqing Pharmaceutical Group
Co., Ltd.
Year of Establishment
1969
Enterprise Size
more than 1000
Annual Turnover(USD)
More than 99,999,999
Company Introduction
CTTQ is a multinational pharmaceutical group with headquarters located in Lianyungang and ranked among the 20th top Chinese pharmaceutical enterprises, with integrated R&D, manufacturing, marketing, sales and distribution;
Aim to be a reference in the pharmaceutical industry, driven by our devotion to the innovation & research of products with technology or production barrier, to improve people’s quality of life and promote human health.
Main Competitive Advantages
Experienced R&D Staff,Large Product Line,Reputation,Quality Service,
Website
http://www.cttq.com
Patents and Copyright
CTTQ filed 1520 patents in China, including 1375 inventions by Jun.30,2020. 518 fillings have been granted including 402 inventions.
199 PCT applications have been filed, of which 166 PCTs have been granted.
Milestone
•1969
Founded in 1969, Dongfeng Pharmaceutical Factory
•1997
A joint venture with Thailand's Chia Tai Group in 1997
•2004
First innovative drug launch in China (Magnesium isoglycyrrhizinate)
•2013
CTTQ Group Foundation as Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
•2015
CTTQ and J&J entered into license agreement for development and commercialization of one innovative drug, for curative treatments for Hepatitis B.
Co-develop innovative drug, Anlotinib was designated as Orphan Drug for treatment of ovarian cancer by FDA; multiple clinical trials ongoing for other indications.